Beacon Biosignals has secured $97 million in funding to advance its work in mapping brain activity during sleep. The company utilizes a wearable EEG headband, which has received FDA clearance, and employs machine learning techniques for its analysis. This technology has already been applied in more than 40 clinical trials targeting neurological and psychiatric conditions such as depression, Alzheimer's, and Parkinson's disease. AI
IMPACT This funding could accelerate the development of AI-driven diagnostics and treatments for neurological disorders.
RANK_REASON Significant funding round for a company using machine learning and an FDA-cleared device for neurological research.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
